I sent an email version of this pitch to interview me, or to share the story to my local TV station. I will modify it slightly for local talk radio and newspapers. I’ve personalized this so that it may be picked up as a human interest story.
If your oncologist is willing to chat with media, that is a bonus. I asked mine if he was willing, and he said that he couldn’t wait.
This is not a media release, just a pitch to get media support. Media support puts credence on the issue.
Good luck. You may or may not hear back. But keep pitching—be an interesting bug in media’s ear. It could be that the media will go on its own and contact a cancer center in your area about GCS, and that’s a good thing.
My email is email@example.com.
September is Gynecologic Cancer Awareness Month. While uterine cancer and other gynecologic cancers are somewhat common, their evil and rare cousins are uterine carcinosarcoma (UCS) and ovarian carcinosarcoma.
I am in treatment for ________ and I wish to bring awareness about this deadly cancer. Why? Even medical professionals that I have dealt with since my diagnosis in _________, had never heard of _______.
From the only working support group for Gynecological Carcinosarcoma (GCS), the GCS Project: “GCS is a rare and aggressive cancer found primarily in the ovaries and uterus…GCS is rare. Fewer than 1,000 cases of GCS are diagnosed each year. Because carcinosarcoma is so rare, there has been limited research or clinical trials that focus on GCS. Unfortunately, this is where the cures will be found. Little or no research results in no cures or effective treatments for us. In order for us to have a fighting chance, we must aggressively support new and ongoing research so that Not One More Woman Will Die from this rotten cancer.”
PERSONALIZE YOUR STORY HERE. HERE IS WHAT I USED:
I’ve had 18 rounds of chemo, two surgeries and radiation. The disease remains active, but in millimeters, for now. Each treatment comes with the clarification, “for your quality of life,” a delicate way to say, these treatments won’t cure the disease.
I am happy to share my story with your listeners (readers). as is my oncologist, ____________________.
My email is _______ mobile, __________. My oncologist, Dr. ______________ can be reached at ________________.
I am faithful _______ News viewer, and I hope there is an interest in this story by you and your reporters.